Procter & Gamble has underperformed the S&P 500, offering total returns of 151.2% over 10 years. Read why I downgrade PG ...
the group has generally underpeformed, with share prices down 2.3% on average over the last month. Procter & Gamble is down 4.2% during the same time and is heading into earnings with an average ...
Crest, Colgate lawsuits target fluoride in kids' toothpaste, mouth rinse Procter & Gamble has promised a group of shareholders it will disclose more details about how it audits wood-pulp suppliers ...
Procter & Gamble's sharp 4.75% single-day-drop is unusual for a low-beta stock, highlighting the need to reassess its position amid market noise. Procter & Gamble's strong brand differentiation ...
Procter & Gamble reported core earnings per share of $1.88, surpassing the $1.86 expectation. Quarterly revenue was $21.9 billion, beating estimates of $21.5 billion. Operating income saw ...
Is now the time to buy Procter & Gamble? Find out in our full research report. Revenue: $21.88 billion vs analyst estimates of $21.59 billion (2.1% year-on-year growth, 1.3% beat) Adjusted EPS ...
In the three months ending December 31, Procter & Gamble's revenue increased 2.1% year over year to $21.9 billion. Its earnings per share (EPS) rose 2.2% from the year-ago period to $1.88.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results